Related Experiment Video
Updated: Feb 12, 2026

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
Published on: February 25, 2021
Ring-opening polymerization-mediated controlled formulation of polylactide-drug nanoparticles.
1Department of Materials Science and Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA.
Researchers developed a novel method to create doxorubicin-polylactide (Doxo-PLA) nanoparticles using controlled polymerization. This technique allows for efficient drug loading and sustained release, offering a promising approach for targeted drug delivery systems.
Area of Science:
- Polymer Chemistry
- Nanotechnology
- Drug Delivery
Background:
- Doxorubicin (Doxo) is a potent chemotherapy drug, but its use is limited by side effects.
- Developing effective drug delivery systems, such as nanoparticles, is crucial for targeted cancer therapy.
- Polylactide (PLA) is a biocompatible polymer often used in drug delivery applications.
Purpose of the Study:
- To develop a unique method for formulating doxorubicin-polylactide (Doxo-PLA) conjugate nanoparticles (NCs).
- To achieve chemo- and regioselective polymerization of lactide (LA) using a novel initiator system.
- To create Doxo-PLA NCs with controlled size, drug loading, and sustained release properties.
Main Methods:
- Utilized Doxo/(BDI)ZnN(TMS)(2)-mediated chemo- and regioselective polymerizations of lactide (LA).
- Employed nanoprecipitation to form Doxo-PLA conjugate nanoparticles (NCs).
- Investigated the effect of steric bulk and metal catalyst on polymerization selectivity and product formation.
Main Results:
- Achieved nearly 100% doxorubicin (Doxo) loading efficiency and 100% lactide (LA) conversion.
- Demonstrated high chemoselectivity, with 1-pyrenemethanol (Pyr-OH) being consumed and covalently linked, while 1-pyrenemethylamine (Pyr-NH(2)) remained intact.
- Formulated Doxo-PLA NCs with sizes under 150 nm and narrow particle size distributions, exhibiting sustained Doxo release without burst release.
Conclusions:
- The developed Doxo/(BDI)ZnN(TMS)(2)-mediated LA polymerization offers a controlled method for creating Doxo-PLA conjugates.
- The resulting nanoparticles demonstrate excellent drug loading, controlled particle size, and sustained drug release profiles.
- This versatile method holds significant potential for the conjugation of hydroxyl-containing agents to polyesters and the formation of advanced nanoparticle delivery systems.
Related Concept Videos
Drug Control Governance: Regulatory Bodies and Their Impact
Olefin Metathesis Polymerization: Ring-Opening Metathesis Polymerization (ROMP)
Actin Polymerization
The nucleation phase involves forming a stable nucleus consisting of three actin monomers to form a new actin filament. Actin-binding proteins such as formins and Arp2/3 complex help filament growth post-nucleation. The Formins form straight...
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Cartesian Form for Vector Formulation
Resultant Moment: Vector Formulation
The resultant moment of a system of forces can be calculated through vector formulation. For example, if we consider...

